Background: Almost half of head and neck (H&N) cancer patients is 65 years or older, however the use of comprehensive geriatric assessment (CGA) to quantify functional age in these patients has not been studied. Moreover, the search for an optimal screening tool to identify patients in need of a full CGA is still ongoing. We examined (1) a disease-specific Combined Screening Tool (CST, "VES-13+(17-G8)"), (2) the feasibility of serial CGA, and (3) its ability to indicate Quality of Life (QoL). Methods: Patients, aged ≥65y, with primary H&N cancer undergoing curative radio(chemo)therapy were evaluated with VES-13, G8, CGA, and EORTC QoL Questionnaire at baseline (W0) and during week 4 (W4) of their therapy at the General Hospital Groeninge or Ghent University Hospital. Receiver Operating Characteristic analysis was used to determine the diagnostic accuracy of the CST. Wilcoxon signed rank test and Mc Nemar's Exact test were performed for comparison of health status at both time points.
